Dr. Larry Einhorn To Be Honored At “A Platinum Celebration”

Praxis Media Group recently completed 5 video elements to be used at an event for Dr. Larry Einhorn celebrating the 40th anniversary of his cure for testicular cancer.  Event held September 27th, 2014 at the Zink Deer Pavillion at the Indianapolis Museum of Art.

Dr. Einhorn takes on the Goliath of all cancers

By Karen Spataro

In 1974, a young, unknown oncologist at the Indiana University School of Medicine added an experimental drug to the chemotherapy regimen for testicular cancer. Seemingly overnight, he turned the research world upside down, and a disease that was almost universally fatal became eminently curable.

Dr. Lawrence EinhornDr. Lawrence Einhorn

More than three decades later, that same physician, Lawrence Einhorn, M.D., is older and grayer, but he retains the same enthusiasm for discovery he harbored as a young doctor. Only now he is focusing on the Goliath of all cancers.

“Lung cancer is the number-one cause of cancer death in America,” Einhorn says matter-of-factly while explaining his current fixation.

He is sitting behind a desk in his unassuming office in the Indiana University Melvin and Bren Simon Cancer Center. The smiling faces of patients whose lives have been touched by his ingenuity keep watch over him from photos that line the walls. Throughout his remarkable career, he has cured untold young men who otherwise would have succumbed to testis cancer, and he has given lung cancer patients precious more time. But he is determined to do better for the latter group.

“No one deserves to die from lung cancer,” says Einhorn, Indiana University Distinguished Professor.

He certainly has his work cut out for him. The odds of surviving a lung cancer diagnosis are slim. Once the cancer has spread, fewer than 4 percent of patients live to see another five birthdays. The result: Nearly 160,000 Americans are lost to the disease each year. That’s more than are killed by prostate, breast and colorectal cancers combined. Especially troubling is the fact that the disease is on the rise among nonsmokers, particularly young women.

Put simply, there are few good treatment options.

Perhaps not surprisingly, Einhorn suspects the answer to the vicious disease might involve platinum-based drugs — the same kind he used to revolutionize the treatment of testicular cancer. To that end, he has helped assemble a multidisciplinary team of researchers to figure out how to unlock the magic of platinum for lung cancer.